Disclosures for "Proximal Complement Inhibition in Generalized Myasthenia Gravis"
-
Dr. Shelly has or had stock in Remepy.
-
Dr. Lalla has nothing to disclose.
-
Dr. ZHAO has received personal compensation for serving as an employee of Dianthus Therapeutics. Dr. ZHAO has received personal compensation for serving as an employee of Viridian Therapeutics. Dr. ZHAO has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roivant. Dr. ZHAO has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MindImmune Therapeutics. Dr. ZHAO has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slater Tech Fund.
-
Dr. Rehaume has received personal compensation for serving as an employee of Dianthus Therapeutics, Inc. Dr. Rehaume has received personal compensation for serving as an employee of Aurinia Pharmaceuticals Inc. Dr. Rehaume has stock in Aurinia Pharmaceuticals Inc.
-
Dr. Cross has received personal compensation for serving as an employee of Dianthus Therapeutics. Dr. Cross has stock in Dianthus Therapeutics.
-
Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR.